GPTHEALTHGPT Healthcare Limited
Healthcare · Medical Care Facilities · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on GPTHEALTH — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 17.8% YoY
- • Profit growth: 64.9% YoY
- • ROCE: 16.3%
- • Golden cross setup: SMA50 above SMA200
- • Trend strength (ADX): 38
- • Volatility: 27% annualized
Bull case
- • Revenue growth: 17.8% YoY
- • Profit growth: 64.9% YoY
- • ROCE: 16.3%
- • Golden cross setup: SMA50 above SMA200
Bear case
- • RSI: 21
- • MACD: bearish
- • 1-month return: -19.7%
- • 1-month vs NIFTY: -16.7% relative
Key risks
- • Momentum is fading versus the broader market
- • RSI: 21
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹4.88). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.